Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1HIV Infections 1

Interventions

nirogacestat 1Transplantation Conditioning 1Taxes 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Platinum 1Paclitaxel 1Independent Medical Evaluation 1Cisplatin 1Carboplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × HIV Infections × Transplantation Conditioning × Clear all
NCT02378922 2018-12-27

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Fred Hutchinson Cancer Center

Phase 1 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡